Bender Robert & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,202
| Closed | -$799K | – | 41 |
|
|
2024
Q4 | $799K | Sell |
12,202
-1,680
| -12% | -$110K | 0.19% | 28 |
|
|
2024
Q3 | $1.08M | Buy |
+13,882
| New | +$1.08M | 0.23% | 27 |
|
|
2024
Q2 | – | Sell |
-18,813
| Closed | -$1.27M | – | 7 |
|
|
2024
Q1 | $1.27M | Sell |
18,813
-4,365
| -19% | -$296K | 0.3% | 28 |
|
|
2023
Q4 | $1.56M | Sell |
23,178
-5,441
| -19% | -$366K | 0.39% | 26 |
|
|
2023
Q3 | $1.94M | Sell |
28,619
-2,977
| -9% | -$202K | 0.57% | 25 |
|
|
2023
Q2 | $2.26M | Sell |
31,596
-12,664
| -29% | -$906K | 0.62% | 25 |
|
|
2023
Q1 | $3.07M | Buy |
44,260
+30
| +0.1% | +$2.08K | 0.95% | 22 |
|
|
2022
Q4 | $3M | Sell |
44,230
-2,185
| -5% | -$148K | 1.12% | 23 |
|
|
2022
Q3 | $2.55M | Buy |
46,415
+961
| +2% | +$52.7K | 0.99% | 24 |
|
|
2022
Q2 | $3M | Sell |
45,454
-884
| -2% | -$58.4K | 1.15% | 24 |
|
|
2022
Q1 | $3.07M | Sell |
46,338
-241
| -0.5% | -$16K | 0.88% | 23 |
|
|
2021
Q4 | $2.8M | Hold |
46,579
| – | – | 0.81% | 25 |
|
|
2021
Q3 | $2.8M | Buy |
+46,579
| New | +$2.8M | 0.8% | 25 |
|